Literature DB >> 18360821

Fatal familial insomnia: Clinical features and early identification.

Anna Krasnianski1, Mario Bartl, Pascual J Sanchez Juan, Uta Heinemann, Bettina Meissner, Daniela Varges, Ulf Schulze-Sturm, Haus A Kretzschmar, Walter J Schulz-Schaeffer, Inga Zerr.   

Abstract

Our aim was to develop a detailed clinical description of fatal familial insomnia in a large patient group with respect to the M129V genotype. Data on 41 German fatal familial insomnia patients were analyzed. Clinical features, 14-3-3 proteins in the cerebrospinal fluid, magnetic resonance imaging, positron emission tomography, single-photon emission computed tomography, polysomnography, and electroencephalography were studied. Age at disease onset, disease duration, and clinical syndrome varied depending on the codon 129 genotype. Because the sensitivity of the most diagnostic tests is low in fatal familial insomnia, detailed clinical investigation is extremely important. Polysomnography may help to support the diagnosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18360821     DOI: 10.1002/ana.21358

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  27 in total

Review 1.  Genetic PrP Prion Diseases.

Authors:  Mee-Ohk Kim; Leonel T Takada; Katherine Wong; Sven A Forner; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

Review 2.  Clinical Laboratory Tests Used To Aid in Diagnosis of Human Prion Disease.

Authors:  Allyson Connor; Han Wang; Brian S Appleby; Daniel D Rhoads
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

3.  A case of fatal familial insomnia in Africa.

Authors:  Elisa Baldin; Sabina Capellari; Federica Provini; Patrizia Corrado; Rocco Liguori; Piero Parchi; Pasquale Montagna; Pietro Cortelli
Journal:  J Neurol       Date:  2009-06-14       Impact factor: 4.849

4.  Metabolic patterns in prion diseases: an FDG PET voxel-based analysis.

Authors:  Elena Prieto; Inés Domínguez-Prado; Mario Riverol; Sara Ortega-Cubero; María Jesús Ribelles; María Rosario Luquin; Purificación de Castro; Javier Arbizu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-06-04       Impact factor: 9.236

5.  Clinical findings and diagnosis in genetic prion diseases in Germany.

Authors:  Anna Krasnianski; Uta Heinemann; Claudia Ponto; Jasmine Kortt; Kai Kallenberg; Daniela Varges; Walter J Schulz-Schaeffer; Hans A Kretzschmar; Inga Zerr
Journal:  Eur J Epidemiol       Date:  2015-06-16       Impact factor: 8.082

6.  Requirements for mutant and wild-type prion protein misfolding in vitro.

Authors:  Geoffrey P Noble; Daniel J Walsh; Michael B Miller; Walker S Jackson; Surachai Supattapone
Journal:  Biochemistry       Date:  2015-01-22       Impact factor: 3.162

Review 7.  Neuroimaging in Dementia.

Authors:  Adam M Staffaroni; Fanny M Elahi; Dana McDermott; Kacey Marton; Elissaios Karageorgiou; Simone Sacco; Matteo Paoletti; Eduardo Caverzasi; Christopher P Hess; Howard J Rosen; Michael D Geschwind
Journal:  Semin Neurol       Date:  2017-12-05       Impact factor: 3.420

Review 8.  Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature.

Authors:  Leonel T Takada; Mee-Ohk Kim; Ross W Cleveland; Katherine Wong; Sven A Forner; Ignacio Illán Gala; Jamie C Fong; Michael D Geschwind
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-01       Impact factor: 3.568

9.  Clinical, histopathological and genetic studies in a case of fatal familial insomnia with review of the literature.

Authors:  Bin Peng; Shenqi Zhang; Hongjuan Dong; Zuneng Lu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

10.  Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study.

Authors:  Raffaele Lodi; Piero Parchi; Caterina Tonon; David Manners; Sabina Capellari; Rosaria Strammiello; Rita Rinaldi; Claudia Testa; Emil Malucelli; Barbara Mostacci; Giovanni Rizzo; Giulia Pierangeli; Pietro Cortelli; Pasquale Montagna; Bruno Barbiroli
Journal:  Brain       Date:  2009-09-15       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.